Consolidated Balance Sheet - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 667	$ 2,150
Receivables, Net, Current	1,355	1,655
Inventories	239	274
Derivative assets	173	239
Other current assets and deferred charges	176	195
Total current assets	2,610	4,513
Investments	4,639	4,637
Property, Plant and Equipment, Gross	54,305	51,842
Accumulated depreciation and amortization	(17,854)	(17,531)
Property, plant, and equipment - net	36,451	34,311
Intangible assets – net of accumulated amortization	7,496	7,593
Regulatory assets, deferred charges, and other	1,551	1,573
Total assets	52,747	52,627
Current liabilities:
Accounts payable	1,042	1,379
Derivative Liability, Current	75	105
Accrued and other current liabilities	1,077	1,284
Commercial Paper	0	725
Long-term debt due within one year	2,787	2,337
Total current liabilities	4,981	5,830
Long-term debt	24,100	23,376
Deferred income tax liabilities	4,001	3,846
Regulatory liabilities, deferred income, and other	4,735	4,684
Contingent liabilities and commitments (Note 9)
Stockholders’ equity:
Preferred stock ($1 par value; 30 million shares authorized at March 31, 2024 and December 31, 2023; 35,000 shares issued at March 31, 2024 and December 31, 2023)	35	35
Common stock ($1 par value; 1,470 million shares authorized at March 31, 2024 and December 31, 2023; 1,258 million shares issued at March 31, 2024 and 1,256 million shares issued at December 31, 2023)	1,258	1,256
Capital in excess of par value	24,564	24,578
Retained deficit	(12,238)	(12,287)
Accumulated other comprehensive income (loss)	10	0
Treasury stock, at cost (39 million shares at March 31, 2024 and December 31, 2023 of common stock)	(1,180)	(1,180)
Total stockholders’ equity	12,449	12,402
Noncontrolling interests in consolidated subsidiaries	2,481	2,489
Total equity	14,930	14,891
Total liabilities and equity	$ 52,747	$ 52,627